{"transactions":[{"id":986516,"issuer":{"id":8244,"kind":"organization","name":"Kairos Pharma, LTD."},"owners":[{"id":72501,"kind":"person","name":"Keyoung Hansoo Michael","position":1,"cik":"0001824764","reported_name":"Keyoung Hansoo Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-11-26T17:27:13.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":19084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 19,084 RSUs) issued to the Reporting Person under the Plan. The 19,084 RSUs are scheduled to vest in full on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of (i) 3,334 shares of common stock and (ii) 25,750 RSUs which remain subject to vesting."}],"balance_after":29084,"source":{"system":"sec-edgar","filing":"0001493152-25-025205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824764/000149315225025205/ownership.xml","form_type":"4"}},{"id":986515,"issuer":{"id":8244,"kind":"organization","name":"Kairos Pharma, LTD."},"owners":[{"id":72501,"kind":"person","name":"Keyoung Hansoo Michael","position":1,"cik":"0001824764","reported_name":"Keyoung Hansoo Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-11-26T17:27:13.000Z","date":"2025-09-16","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 10,000 restricted stock units (\"RSUs\") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan (the \"Plan\"). The 10,000 RSUs were granted on September 16, 2024, in conjunction with the Issuer's initial public offering (IPO), and grant in substantially equal installments on the anniversary date of the IPO."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 3,334 shares of common stock and (ii) 6,666 RSUs which remain subject to vesting."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-25-025205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824764/000149315225025205/ownership.xml","form_type":"4"}},{"id":3020579,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":72501,"kind":"person","name":"Keyoung Hansoo Michael","position":1,"cik":"0001824764","reported_name":"Keyoung Hansoo Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-09-29T20:40:20.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":1133596,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by AffaMed Project Limited (\"AffaMed\"). Mengjiao Jiang and the Reporting Person are the directors of AffaMed and each of them may be deemed to hold shared voting and dispositive power with respect to the shares held by AffaMed. The Reporting Person disclaims beneficial ownership of the securities held by AffaMed except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1133596},"source":{"system":"sec-edgar","filing":"0001209191-20-052340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120052340/doc4.xml","form_type":"4"}},{"id":3020578,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":72501,"kind":"person","name":"Keyoung Hansoo Michael","position":1,"cik":"0001824764","reported_name":"Keyoung Hansoo Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T20:40:20.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":1133596,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by AffaMed Project Limited (\"AffaMed\"). Mengjiao Jiang and the Reporting Person are the directors of AffaMed and each of them may be deemed to hold shared voting and dispositive power with respect to the shares held by AffaMed. The Reporting Person disclaims beneficial ownership of the securities held by AffaMed except to the extent of his pecuniary interest therein, if any."}],"balance_after":1133596,"source":{"system":"sec-edgar","filing":"0001209191-20-052340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120052340/doc4.xml","form_type":"4"}}]}